ATE268784T1 - Peptidfragment von lalf mit antiviraler wirkung - Google Patents

Peptidfragment von lalf mit antiviraler wirkung

Info

Publication number: ATE268784T1
Authority: AT; Austria
Prior art keywords: lalf; peptide; hep; induce; effect
Prior art date: 1997-09-29

Application number

AT98203293T

Other languages

English (en)

Inventor

Vallespi Maribel Guerra

Jesus Arana Rosainz Manuel De

Plaza Ayuntamiento

Original Assignee

Ct Ingenieria Genetica Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-29

Filing date

1998-09-29

Publication date

2004-06-15

1998-09-29 Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE268784T1 publication Critical patent/ATE268784T1/de

Links

230000000840 anti-viral effect Effects 0.000 title abstract 3
101000779583 Limulus polyphemus Anti-lipopolysaccharide factor Proteins 0.000 title 1
108010033276 Peptide Fragments Proteins 0.000 title 1
102000007079 Peptide Fragments Human genes 0.000 title 1
108010009352 antilipopolysaccharide factor (Limulus) Proteins 0.000 abstract 4
210000004027 cell Anatomy 0.000 abstract 2
230000001900 immune effect Effects 0.000 abstract 2
230000028993 immune response Effects 0.000 abstract 2
GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010037660 Pyrexia Diseases 0.000 abstract 1
230000001627 detrimental effect Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
210000005087 mononuclear cell Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
239000006228 supernatant Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Insects & Arthropods (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT98203293T 1997-09-29 1998-09-29 Peptidfragment von lalf mit antiviraler wirkung ATE268784T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CU1997106A CU22700A1 (es)	1997-09-29	1997-09-29	Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso

Publications (1)

Publication Number	Publication Date
ATE268784T1 true ATE268784T1 (de)	2004-06-15

Family

ID=5459370

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98203293T ATE268784T1 (de)	1997-09-29	1998-09-29	Peptidfragment von lalf mit antiviraler wirkung

Country Status (10)

Country	Link
US (2)	US6191114B1 (de)
EP (1)	EP0905141B1 (de)
CN (1)	CN1218057A (de)
AT (1)	ATE268784T1 (de)
CU (1)	CU22700A1 (de)
DE (1)	DE69824358T2 (de)
DK (1)	DK0905141T3 (de)
ES (1)	ES2223105T3 (de)
PT (1)	PT905141E (de)
SI (1)	SI0905141T1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040199099A1 (en) *	1998-07-10	2004-10-07	Matson James R	Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US6592869B2 (en)	1999-08-24	2003-07-15	Teva Pharmaceutical Industries, Ltd.	Vaccine composition and method of using the same
HUP0202537A3 (en)	1999-08-24	2004-05-28	Teva Pharma	A vaccine composition and method of using the same
US7291122B2 (en) *	2000-03-24	2007-11-06	Immunocept, L.L.C.	Hemofiltration methods for treatment of diseases in a mammal
US6787040B2 (en) *	2000-05-16	2004-09-07	Immunocept, L.L.C.	Method and system for colloid exchange therapy
AT410635B (de)	2000-10-18	2003-06-25	Cistem Biotechnologies Gmbh	Vakzin-zusammensetzung
WO2004014315A2 (en) *	2002-08-13	2004-02-19	Arbios Systems, Inc.	Selective plasma exchange therapy
CU23389B6 (es) *	2005-12-29	2009-07-16	Ct Ingenieria Genetica Biotech	Combinación farmacéutica citoprotectora, útil en la prevención y tratamiento del síndrome de respuesta inflamatoria sistémica
CU23582A1 (es)	2006-02-24	2010-10-30	Ct Ingenieria Genetica Biotech	Péptidos con capacidad anti-tumoral e inmunomoduladora
EP2108372A1 (de) *	2008-04-09	2009-10-14	Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften	Neue antimikrobielle Peptide
CN113563427B (zh) *	2021-06-02	2022-02-01	北京师范大学珠海校区	抗菌短肽lbd-s及其应用和药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006892A (en)	1991-05-16	1992-12-30	Associates Of Cape Cod, Inc.	Endotoxin binding and neutralizing protein and uses thereof
JPH08503490A (ja) *	1993-08-18	1996-04-16	モルフォシス・ゲゼルシャフト・フュア・プロタインオプティミールング・ミット・ベシュレンクテル・ハフツング	リポ多糖結合性および中和能のあるペプチド
US5780429A (en) *	1995-12-22	1998-07-14	Marine Biological Laboratory	Anti-LPS factor from horseshoe crabs and methods of use

1997
- 1997-09-29 CU CU1997106A patent/CU22700A1/es unknown
1998
- 1998-09-25 US US09/160,309 patent/US6191114B1/en not_active Expired - Fee Related
- 1998-09-29 CN CN98124538A patent/CN1218057A/zh active Pending
- 1998-09-29 DE DE69824358T patent/DE69824358T2/de not_active Expired - Fee Related
- 1998-09-29 DK DK98203293T patent/DK0905141T3/da active
- 1998-09-29 EP EP98203293A patent/EP0905141B1/de not_active Expired - Lifetime
- 1998-09-29 AT AT98203293T patent/ATE268784T1/de not_active IP Right Cessation
- 1998-09-29 PT PT98203293T patent/PT905141E/pt unknown
- 1998-09-29 SI SI9830682T patent/SI0905141T1/xx unknown
- 1998-09-29 ES ES98203293T patent/ES2223105T3/es not_active Expired - Lifetime
2000
- 2000-10-18 US US09/691,500 patent/US6632793B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69824358T2 (de)	2005-06-09
DK0905141T3 (da)	2004-10-25
US6632793B1 (en)	2003-10-14
DE69824358D1 (de)	2004-07-15
US6191114B1 (en)	2001-02-20
EP0905141B1 (de)	2004-06-09
PT905141E (pt)	2004-10-29
SI0905141T1 (en)	2004-12-31
CN1218057A (zh)	1999-06-02
ES2223105T3 (es)	2005-02-16
CU22700A1 (es)	2001-07-31
EP0905141A1 (de)	1999-03-31

Similar Documents

Publication	Publication Date	Title
DE69824358D1 (de)	2004-07-15	Peptidfragment von LALF mit antiviraler Wirkung
CY1112927T1 (el)	2016-04-13	Αντισωματα κατα της ανθρωπινης il-12
DE3484616D1 (de)	1991-06-27	Enzymwiderstandsfaehige immunomodulatorische peptide.
DE68926859D1 (de)	1996-08-22	Natürlicher killerzellen-stimulationsfaktor
TR200001228T2 (tr)	2001-01-22	T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
EP0730609A4 (de)	2000-05-10	In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE3582973D1 (de)	1991-07-04	Neues derivat des humangammainterferon-polypeptids.
SE503436C2 (sv)	1996-06-17	Pyroglutamidderivat
ATE218616T1 (de)	2002-06-15	Humanes zirkulierendes cytokin cc-1
GT198301619A (es)	1984-08-21	Interferon inmune humano homogeneo y procedimiento para el mismo.
MX170929B (es)	1993-09-22	Empleo de substancias antigenicas para la profilaxis o la terapia de transtornos y enfermedades en el conducto digestivo de animales y humanos
NO931413L (no)	1993-04-16	Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
KR870004971A (ko)	1987-06-02	티아졸론 및 이의 제조방법
IT7967029A0 (it)	1979-01-08	Amminoderivati della pirazolo i 5 as triazina particolarmente utili in terapia e procedimento per la loropreparazione
FI924475A7 (fi)	1992-10-05	Trinitrobentseenien tai karmiinihapon käyttö syövän ja virusperäisten sairauksien hoidossa
DK0546036T3 (da)	1997-11-03	Vacciner
IT8268521A0 (it)	1982-12-24	Abitacolo termico solare per il trattamento di persone e o animali agli effetti dei raggi solari in particolare per la sauna solare
IT1213100B (it)	1989-12-07	La produzione di prodotti sessuali impiego di sostanze stimolanti per da mammiferi,adatti per la fecondazione naturale ed artificiale e sostanze relative
ES2018370A6 (es)	1991-04-01	Un procedimiento para la preparacion de un gel de poliacrilato sodico.
ATE30238T1 (de)	1987-10-15	N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
DK0540560T3 (da)	1995-12-27	Ancrod-lignende proteiner, fremstilling og anvendelse deraf
DE69003216D1 (de)	1993-10-14	Verwendung von somatostatin.
IT8920643A0 (it)	1989-05-25	Impiego della farina di fibra di nocciola in campo dietetico per l'ottenimento di effetti dimagranti e di migliorato assorbimento intestinale degli amminoacidi.
JPS526474A (en)	1977-01-18	Electric charge transfer element
ES290272U (es)	1986-04-01	Pulsera

Legal Events

Date

Code

Title

Description

2005-02-15

UEP

Publication of translation of european patent specification

Ref document number: 0905141

Country of ref document: EP

2007-06-15

REN

Ceased due to non-payment of the annual fee